Skip to main content

Table 5 Baseline Distribution among the Model Health States after Random Selection of Patients (n = 213 per arm)

From: Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Base Health State

CD4 Range

VL Range

EFV Number of Patients

LPV/r Number of Patients

2

>500

>400

7

7

4

350-499

>400

29

29

6

200-349

400-10,000

22

22

7

200-349

>10,000

47

47

9

50-199

400-10,000

6

6

10

50-199

10,001-100,000

25

25

11

50-199

>100,000

28

28

12

<50

Any

49

49